August 26th-27th, 2021, GCT CEO, Dr. Eugene Selivra, and Senior Director of BD, Natalia Katsnelson are participating at #WODCUSA in Oxon Hill, MD.

We are excited to be back to in-person conferences this month! We are looking forward to sharing our experience in conducting #raredisease clinical trials globally in today’s environment and to meet industry peers.

The 11th annual World Orphan Drug Congress USA is planned to be held in person to meet, brainstorm, and discuss the ways to advance the development of orphan drugs and improve access to life-saving treatments.

To schedule a meeting, please contact us at or directly through the conference platform

We look forward to seeing you there!